张迎强, 林岩松. Application and research progress of90Y microspheres internal radiation therapy in colorectal cancer with liver metastasis[J]. China Oncology, 2021, 31(8): 762-768.
张迎强, 林岩松. Application and research progress of90Y microspheres internal radiation therapy in colorectal cancer with liver metastasis[J]. China Oncology, 2021, 31(8): 762-768. DOI: 10.19401/j.cnki.1007-3639.2021.08.010.
Application and research progress of90Y microspheres internal radiation therapy in colorectal cancer with liver metastasis
结直肠癌(colorectal cancer,CRC)是全球死亡率第2位的恶性肿瘤,高达50%的患者在初诊或治疗后出现肝转移,成为CRC患者的主要致死原因。对于结直肠癌肝转移(colorectal cancer with liver metastases,CRLM)患者,在系统治疗的基础上联合局部治疗是目前最主要的治疗方式。作为局部微创治疗的重要手段之一,放射性核素钇-90(yttrium-90,
90
Y)微球选择性内放射治疗(selective internal radiation therapy,SIRT)在国外已有近20年的临床使用经验,大量临床研究证明了其治疗肝脏肿瘤的疗效和安全性。美国国立综合癌症网络(National Comprehensive Cancer Network,NCCN)、欧洲肿瘤内科学会(European Society for Medical Oncology,ESMO)等国际指南均推荐
90
Y微球SIRT作为CRLM患者的局部微创治疗选择。在国内,中国临床肿瘤学会(Chinese Society of Clinical Oncology,CSCO)发布的《结直肠癌诊疗指南(2019)》亦将
Colorectal cancer (CRC) is the second leading cause of cancer death worldwide. Hepatic metastases
which account for the major cause of mortality in CRC patients
occur in about half of the patients when the primary tumor is discovered or after the treatment. Local treatment along with syste
matic therapy is the most common schedule for CRC patients with liver metastases (CRLM). As one of the well-accepted minimally invasive local therapies
yttrium-90 (
90
Y)-microspheres selective internal radiotherapy (SIRT) has shown its confirmed efficacy and safety and been applied in CRLM patients abroad for nearly 20 years. National Comprehensive Cancer Network (NCCN) and European Society for Medical Oncology (ESMO) guidelines recommend
90
Y microspheres SIRT as a local minimally invasive treatment option for CRLM patients. The Guidelines for the Diagnosis and Treatment of Colorectal Cancer (2019) issued by Chinese Society of Clinical Oncology (CSCO) also recommended
90
Y-microspheres SIRT at level Ⅲ. In this study
we reviewed the progress of
90
Y-microspheres SIRT in terms of palliative and translational treatment for metastatic colorectal cancer (mCRC)
which indicated that
90
Y-microspheres SIRT had the advantages in local control as well as the improvement of survival time and living quality
either alone or combined with other local or systemic therapies.
Targeted therapy and immunotherapy combined with chemotherapy bring effective response to AFP positive colon cancer patients: a case report and literature review
Mechanisms underlying tepoxalin-mediated regulation of cell growth and chemoresistance via ABCB1 in colorectal cancer
Research progress and prospects of exercise intervention in comprehensive management of colorectal cancer
The impact of participation status on the colorectal cancer incidence, stage and survival outcomes in the Shanghai colorectal cancer screening program
Artificial intelligence-based assessment of surgical skills in laparoscopic right hemicolectomy for colon cancer
Related Author
LIU Miao
LI Jinze
WU Chensi
ZHANG Fengbin
GAO Hongsheng
ZHANG Ruixing
Zhijun HE
Liwen JIN
Related Institution
Department of Pathology, the Fourth Hospital of Hebei Medical University
Department of Gastroenterology, the Fourth Hospital of Hebei Medical University
Department of Oncology, Shanghai Pudong New District Zhoupu Hospital
Cancer Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Gastroenterology, Shanghai Pudong New District Zhoupu Hospital